- Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implicationsYang Kai; Wang Jian; Lu WenjuExperimental Physiology, 2017, 102(9): 1083-1089.
- The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptorsClapp Lucie H; Gurung RijanProstaglandins and Other Lipid Mediators, 2015, 120: 56-71.
- Germline and Somatic Mutations in DNA Methyltransferase 3A (DNMT3A) Predispose to Pulmonary Arterial Hypertension (PAH) in Humans and Mice: Implications for Associated PAH.Ruaa Al Qazazi; Isaac M Emon; François Potus; Ashley Y Martin; Patricia D A Lima; Caitlyn Vlasschaert; Kuang Hueih Chen; Danchen Wu; Asish Das Gupta; Curtis Noordhof; Lindsay Jefferson; Amy J M McNaughton; Alexander G Bick; Michael W Pauciulo; William C Nichols; Wendy K Chung; Paul M Hassoun; Rachel L Damico; Michael J Rauh; Stephen L ArchermedRxiv : the preprint server for health sciences , 2023.
会议论文
GALNT1-mediated O-GalNAc Glycosylation Is a Novel Mediator of Pulmonary Arterial Hypertension
14阅读
